The U.S. Department of Veterans Affairs (VA) awarded a $100,800.00 Firm Fixed Price Delivery Order contract to Grifols USA LLC for the provision of PROLASTIN-C, an alpha1-proteinase inhibitor drug used to treat alpha1-antitrypsin deficiency. This contract is part of Grifols' $1.38 billion Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the VA. The contract has a period of performance through February 8, 2026 and was awarded without a set-aside designation, indicating Grifols' status as a large business capable of meeting the VA's pharmaceutical needs. Grifols is a global healthcare company that specializes in the development, manufacturing, and distribution of plasma-derived medicines and other pharmaceutical products, and has supplied critical drugs to various federal agencies, including the VA and Department of Justice.
Generated 10/30/24, 10:02 AM